Patent · US Active

Method for inactivating Zika virus and for determining the completeness of inactivation

US11478541B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

Takeda Vaccines, Inc. · US

Inventors

Jill A. Livengood · Fort Collins, US
Holli Giebler · Cambridge, US
Hansi DEAN · Cambridge, US
Tatsuki Satou · Hikari, JP
Raman K. Rao · Palo Alto, US
Jackie Marks · Cambridge, US
Mark Lyons · Cambridge, US
Asae Shintani · Suita, JP
James Gifford · Somerville, US

Key dates

Filing date	Nov 5, 2018
Grant date	Oct 25, 2022
Priority date	—
Expiry date	Nov 5, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/24164
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to methods for inactivating a Zika virus which can be used in vaccines and immunogenic compositions. The present disclosure also relates to a method for determining the completeness of inactivation of an arbovirus preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.